Robert E. Hoffman - 08 Nov 2021 Form 4 Insider Report for Kintara Therapeutics, Inc. (HURA)

Reporting relationship: President and CEO, Director
Issuer ticker: HURA
Reported as of: 08 Nov 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Nov 2021, 15:18:07 UTC
Prior SEC filing: 22 Sep 2021
Next SEC filing: 17 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Robert Hoffman

Key filing fact

Robert E. Hoffman filed Form 4 for Kintara Therapeutics, Inc. (HURA) on 10 Nov 2021.

Key facts

This page summarizes Robert E. Hoffman's Form 4 filing for Kintara Therapeutics, Inc. (HURA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Nov 2021, 15:18.

Change

Previous filing in this sequence was filed on 22 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KTRA transaction Derivative

Options (Right to Buy)

Award

Transaction value: $0
Shares: +3,519,170
Change %
Price: $0.000000
Shares after: 3,519,170
Date: 08 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,519,170
Exercise price: $0.9600
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option award was made to the reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment, the shares subject to the option shall vest as follows: 25% of the shares subject to the option shall vest on November 8, 2022, and the remainder shall vest in equal monthly installments over the following thirty-six (36) months.

SEC remarks

Exhibit 24 - Power of Attorney